March 16, 2015 / 1:22 PM / 3 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Valeant, Microvision, FXCM, King Digital

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, U.S. stock index futures were up on Monday, putting the benchmark S&P 500 on track for a rebound after three weeks of losses. Dow Jones industrial e-mini average futures were up 0.63 percent at 17,840, S&P 500 e-mini futures were up 0.66 percent at 2,063.25 and Nasdaq 100 e-mini futures were up 0.56 percent at 4,333.

** VALEANT PHARMACEUTICALS INTERNATIONAL INC, Friday close $197.43, +1.24 pct premarket

** SALIX PHARMACEUTICALS INC Friday close $169.4, +2.63 pct premarket

** ENDO INTERNATIONAL PLC $87.33, +0.89 pct premarket

Valeant Pharmaceuticals International said it increased its offer for Salix to $10.96 billion in cash, topping Endo International’s bid of $10.93 billion in cash-and-stock for the bowel drug maker.

** LIFE TIME FITNESS INC, Friday close $67.2, +5.18 pct premarket

The gym operator said it would be taken private by Leonard Green & Partners and TPG in a deal valued over $4 billion. The $72.10 per-share deal represents a 7.3 percent premium to Life Time’s Friday close.

** NETFLIX INC, Friday close $438.4, -1.76 pct premarket

Evercore ISI cut its rating on the streaming video service provider to “sell” from “hold” and lowered the price target to $380 from $450, citing strengthening competition and need for investments.

** DUPONT, Friday close $80.5, -2.16 pct premarket

BofA Merrill Lynch downgrades the chemical company to “underperform” from “buy”, citing headwinds in agriculture and chemicals business against the backdrop of a strong dollar.

** MICROVISION INC, Friday close $2.74, +16.06 pct premarket

Laser projector maker said it received a $14.5 million order from a Fortune global 100 client. The company plans to start shipments in second half of 2015.

** BOSTON SCIENTIFIC CORP, Friday close $16.61, +3.55 pct premarket

FDA approves medical device maker’s device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation (AF). Credit Suisse, Barclays and BMO Capital Markets raise price target to $19 from $18.

** MIDSTATES PETROLEUM COMPANY INC, Friday close $0.7651, +33.32 pct premarket

Oil and gas producer’s reports fourth-quarter adjusted profit of 19 cents/share above average analyst estimate of 2 cents, helped by higher production, lower expenses. Company expects 2015 production of 30,000-33,000 boepd, compared with 2014 average production 32,137 boepd

** KING DIGITAL ENTERTAINMENT PLC, Friday close $14.9, +6.04 pct premarket

JP Morgan raised rating to “overweight” from “neutral”, citing the success of Candy Crush Soda Saga and expected launch of five new games this year. JP Morgan said in a note, “Candy Crush Saga has a longer tail than we anticipated, & sister title Candy Crush Soda Saga is off to a strong start & has reinvigorated the entire Candy franchise.”

** INOTEK PHARMACEUTICALS CORP, Friday close $5.69, +6.85 pct premarket

Cowen and Company starts drug developer’s coverage with “outperform” and $15 price target; Piper Jaffray with “overweight” and $9 target. Cowen and Piper Jaffray were joint book-running managers to the company’s IPO.

** FXCM INC, Friday close $2.58, -10.85 pct premarket

Keefe, Bruyette & Woods downgraded the retail currency broker’s stock to “underperform” from “marketperform”. KBW said in a note, “We ... lower our 2015 estimates to reflect the higher customer deficit than initially announced and the weaker February activity in institutional and retail accounts.”

** IDREAMSKY TECHNOLOGY LTD, Friday close $10.82, -15.43 pct premarket

The Chinese mobile game distributor estimated fourth-quarter revenue of $52.7 million-$53 million, below its forecast of $62.9 million-$66.1 million, citing delay in launching a game and less-than-expected revenue from another game.

** CTI BIOPHARMA CORP, Friday close $1.97, +6.09 pct premarket

The drugmaker said about 31 percent of patients who qualified for evaluation in a mid-stage trial of its blood cancer drug, pacritinib, had their spleen size reduced at least 35 percent. The study results were published in the journal Blood.

** TESLA MOTORS INC, Friday close $188.68, +2.00 pct premarket

The electric car maker will present a software update to its Model S vehicle at a news conference on Thursday that is designed to quell fears that drivers will run out of power for their cars, Chief Executive Elon Musk said on Sunday.

** HANESBRANDS INC, Friday close $32.61, +2.67 pct premarket

** AVON PRODUCTS INC, Friday close $7.72

Hanesbrands will replace Avon in the S&P 500 after the close on March 20, S&P Dow Jones Indices said on Friday.

Compiled by Kshitiz Goliya; Editing by Sriraj Kalluvila

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below